Ghaith Aljayyoussi
Pharmacokinetic-Pharmacodynamic modelling of intracellular Mycobacterium tuberculosis growth and kill rates is predictive of clinical treatment duration
Aljayyoussi, Ghaith; Jenkins, Victoria A.; Sharma, Raman; Ardrey, Alison; Donnellan, Samantha; Ward, Stephen A.; Biagini, Giancarlo A.
Authors
Victoria A. Jenkins
Raman Sharma
Alison Ardrey
Dr Samantha Donnellan S.Donnellan@napier.ac.uk
Lecturer
Stephen A. Ward
Giancarlo A. Biagini
Abstract
Tuberculosis (TB) treatment is long and complex, typically involving a combination of drugs taken for 6 months. Improved drug regimens to shorten and simplify treatment are urgently required, however a major challenge to TB drug development is the lack of predictive pre-clinical tools. To address this deficiency, we have adopted a new high-content imaging-based approach capable of defining the killing kinetics of first line anti-TB drugs against intracellular Mycobacterium tuberculosis (Mtb) residing inside macrophages. Through use of this pharmacokinetic-pharmacodynamic (PK-PD) approach we demonstrate that the killing dynamics of the intracellular Mtb sub-population is critical to predicting clinical TB treatment duration. Integrated modelling of intracellular Mtb killing alongside conventional extracellular Mtb killing data, generates the biphasic responses typical of those described clinically. Our model supports the hypothesis that the use of higher doses of rifampicin (35 mg/kg) will significantly reduce treatment duration. Our described PK-PD approach offers a much needed decision making tool for the identification and prioritisation of new therapies which have the potential to reduce TB treatment duration.
Citation
Aljayyoussi, G., Jenkins, V. A., Sharma, R., Ardrey, A., Donnellan, S., Ward, S. A., & Biagini, G. A. (2017). Pharmacokinetic-Pharmacodynamic modelling of intracellular Mycobacterium tuberculosis growth and kill rates is predictive of clinical treatment duration. Scientific Reports, 7(1), Article 502 (2017). https://doi.org/10.1038/s41598-017-00529-6
Journal Article Type | Article |
---|---|
Acceptance Date | Mar 1, 2017 |
Online Publication Date | Mar 29, 2017 |
Publication Date | 2017 |
Deposit Date | Feb 11, 2021 |
Publicly Available Date | Feb 11, 2021 |
Journal | Scientific Reports |
Publisher | Nature Publishing Group |
Peer Reviewed | Peer Reviewed |
Volume | 7 |
Issue | 1 |
Article Number | 502 (2017) |
DOI | https://doi.org/10.1038/s41598-017-00529-6 |
Public URL | http://researchrepository.napier.ac.uk/Output/2718415 |
Files
Pharmacokinetic-Pharmacodynamic modelling of intracellular Mycobacterium tuberculosis growth and kill rates is predictive of clinical treatment duration
(2.5 Mb)
PDF
Publisher Licence URL
http://creativecommons.org/licenses/by/4.0/
Copyright Statement
This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
You might also like
Design of a new class of broad-spectrum therapeutics targeted to drug-resistant bacteria
(2024)
Journal Article
A Quantitative Method for the Study of HIV-1 and Mycobacterium tuberculosis Coinfection
(2022)
Journal Article
Downloadable Citations
About Edinburgh Napier Research Repository
Administrator e-mail: repository@napier.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2025
Advanced Search